• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$39.43 $0.14 (0.36%)

REAL-TIME: Last trade at

St. Jude Medical, Inc.

NYSE:STJ

Jump to this page for:

Related Resources

Plan to Speed Up FDA Reviews Will Look to Benefit Medical Devices Companies

5/25/2012 by Marketwire

Barclays' medical supplies and devices analysts hold a conference call

5/18/2012 by Theflyonthewall.com

BofA/Merrill's medtech analyst research team holds a conference call

5/18/2012 by Theflyonthewall.com

St. Jude Medical Announces FDA Approval of Assura™ Implantable Defibrillators with Features That Reduce Inappropriate Shocks Tachycardia

5/17/2012 by Pharmaceutical and Medical Packaging News

Leerink's medical supplies and devices analysts hold a conference call

5/17/2012 by Theflyonthewall.com

An Exciting New Technology That Could Take Pressure Off St. Jude Medical

5/16/2012 by Seeking Alpha

Global Cables and Leads for Medical Equipment Industry

5/16/2012 by PR Newswire

St. Jude Medical (STJ) Presents Significant Data for TAVI Tech, AMPLATZER Cardiac Plug

5/16/2012 by StreetInsider.com

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

5/16/2012 by StockWatch

St. Jude Medical announces clinical data for structural heart portfolio

5/16/2012 by Theflyonthewall.com

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

5/16/2012 by Business Wire

St. Jude Medical reports EnligHTN renal denervation system safe, effective

5/16/2012 by Theflyonthewall.com

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

5/16/2012 by PharmiWeb.com - UK

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

5/16/2012 by Business Wire

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

5/15/2012 by PharmiWeb.com - UK

St. Jude Medical announces data from FAME II trial

5/15/2012 by Theflyonthewall.com

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

5/15/2012 by Business Wire

China Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

5/15/2012 by PR Newswire

St. Jude Medical announces European approval, launch of EnligHTN system

5/15/2012 by Theflyonthewall.com

Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis

5/14/2012 by PR Newswire

St. Jude Medical Continues Strong Show of PCI Optimization Technologies at EuroPCR

5/14/2012 by PharmiWeb.com - UK

St. Jude Medical Upgraded to “Buy” at Goldman Sachs (STJ)

5/14/2012 by Dividend.com

St. Jude Medical Continues Strong Show of PCI Optimization Technologies at EuroPCR

5/14/2012 by Business Wire

Goldman Sachs Upgrades St. Jude Medical (STJ) to Buy

5/14/2012 by StreetInsider.com

St. Jude Medical upgraded to Buy from Neutral at Goldman

5/14/2012 by Theflyonthewall.com

The Zacks Analyst Blog Highlights: Bed Bath & Beyond, Cost Plus, Target, Wal-Mart and St. Jude Medical

5/11/2012 by PR Newswire

The Zacks Analyst Blog Highlights: Bed Bath & Beyond, Cost Plus, Target, Wal-Mart and St. Jude Medical - Press Releases

5/11/2012 by Zacks Investment Research

St. Jude Medical faces questions about heart device, WSJ reports

5/11/2012 by Theflyonthewall.com

St. Jude Medical announces positive results for SCD-HeFT study

5/10/2012 by Theflyonthewall.com

St. Jude Medical Announces Results of SCD-HeFT 10-Year Follow-up Study

5/10/2012 by Business Wire

Critical Alerts For JP Morgan, CA Technologies, St Jude Medical, Bed Bath & Beyond, and Sina Corp. Released By InvestorsObserver

5/10/2012 by PR Newswire

Critical Alerts For JP Morgan, CA Technologies, St Jude Medical, Bed Bath & Beyond, and Sina Corp. Released By InvestorsObserver

5/10/2012 by StockWatch

6 Flatlining Healthcare Stocks to Sell

5/9/2012 by InvestorPlace

St. Jude Medical (STJ): FDA Clears Ellipse Implantable Device

5/9/2012 by iStockAnalyst

St. Jude Medical (STJ) Gets FDA Approval for Ellipse ICD

5/9/2012 by StreetInsider.com

St. Jude Medical announces FDA approval of Ellipse ICD

5/9/2012 by Theflyonthewall.com

St. Jude Medical Announces FDA Approval of Smaller ICD with Physician Inspired Shape

5/9/2012 by Business Wire

6 Stocks to Sell in May

5/8/2012 by InvestorPlace

St. Jude Medical receives approval for Assura from FDA

5/8/2012 by Theflyonthewall.com

St. Jude Medical to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

5/4/2012 by PharmiWeb.com - UK
See More Articles...